Arkolith/Insider Trading/MURA/Form 4

Loew Caroline

Chief Executive Officer, DirectorMural Oncology plc (MURA) · full profile →Form 4 · filed Jul 8, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$36K
Net Open-Market Flow
-$36K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 8, 2024Sell(S)13K$2.91$36K240K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-082244) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML